Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vindhya Udhane

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The International Journal of Biochemistry & Cell Biology|August 22, 2020
Cytokines, JAK-STAT Signaling and Radiation-Induced DNA Repair in Solid Tumors: Novel Opportunities for Radiation TherapyWilliam A Hall, Lavannya Sabharwal, Vindhya Udhane, et al.
The Journal of Liquid Biopsy|August 12, 2025
Analysis of cerebrospinal fluid tumor-derived DNA to obviate biopsy of IDH-mutant brainstem glioma in an adultMichael Youssef, Alexandra Larson, Vindhya Udhane, et al.
Diseases (Basel, Switzerland)|October 28, 2025
Molecular Analysis of Cerebrospinal Fluid Tumor-Derived DNA to Aid in the Diagnosis and Targeted Treatment of Breast Cancer Brain MetastasisMichael Youssef, Alexandra Larson, Vindhya Udhane, et al.
The Journal of Liquid Biopsy|April 24, 2026
Clinician perspectives on the clinical utility of Belay Summit™ 2.0 cerebrospinal fluid test - A mixed methods studyMatthias Holdhoff, Chen Hu, Vindhya Udhane, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 12, 2019
Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate CancerBassem R Haddad, Andrew Erickson, Vindhya Udhane, et al.
Cancers|October 23, 2021
Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?Paul Beinhoff, Lavannya Sabharwal, Vindhya Udhane, et al.
Cancers|November 21, 2020
Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In VivoCristina Maranto, Vindhya Udhane, Jing Jia, et al.
Diagnostics (Basel, Switzerland)|March 28, 2026
Variant Allelic Frequency to Track Therapy Response and Evaluate Leptomeningeal Disease in Metastatic Central Nervous System CancersVindhya Udhane, Alexandra Larson, Jennifer N Adams, et al.
Molecular Cancer Therapeutics|September 25, 2019
Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 InhibitorsVindhya Udhane, Cristina Maranto, David T Hoang, et al.
Cancers|March 28, 2025
Correction: Maranto et al. Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo. <i>Cancers</i> 2020, <i>12</i>, 3412Cristina Maranto, Vindhya Udhane, Jing Jia, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The International Journal of Biochemistry & Cell Biology|August 22, 2020
Cytokines, JAK-STAT Signaling and Radiation-Induced DNA Repair in Solid Tumors: Novel Opportunities for Radiation TherapyWilliam A Hall, Lavannya Sabharwal, Vindhya Udhane, et al.
The Journal of Liquid Biopsy|August 12, 2025
Analysis of cerebrospinal fluid tumor-derived DNA to obviate biopsy of IDH-mutant brainstem glioma in an adultMichael Youssef, Alexandra Larson, Vindhya Udhane, et al.
Diseases (Basel, Switzerland)|October 28, 2025
Molecular Analysis of Cerebrospinal Fluid Tumor-Derived DNA to Aid in the Diagnosis and Targeted Treatment of Breast Cancer Brain MetastasisMichael Youssef, Alexandra Larson, Vindhya Udhane, et al.
The Journal of Liquid Biopsy|April 24, 2026
Clinician perspectives on the clinical utility of Belay Summit™ 2.0 cerebrospinal fluid test - A mixed methods studyMatthias Holdhoff, Chen Hu, Vindhya Udhane, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 12, 2019
Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate CancerBassem R Haddad, Andrew Erickson, Vindhya Udhane, et al.
Cancers|October 23, 2021
Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?Paul Beinhoff, Lavannya Sabharwal, Vindhya Udhane, et al.
Cancers|November 21, 2020
Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In VivoCristina Maranto, Vindhya Udhane, Jing Jia, et al.
Diagnostics (Basel, Switzerland)|March 28, 2026
Variant Allelic Frequency to Track Therapy Response and Evaluate Leptomeningeal Disease in Metastatic Central Nervous System CancersVindhya Udhane, Alexandra Larson, Jennifer N Adams, et al.
Molecular Cancer Therapeutics|September 25, 2019
Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 InhibitorsVindhya Udhane, Cristina Maranto, David T Hoang, et al.
Cancers|March 28, 2025
Correction: Maranto et al. Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo. <i>Cancers</i> 2020, <i>12</i>, 3412Cristina Maranto, Vindhya Udhane, Jing Jia, et al.
Pageof 2